National Healthcare Corp

National Healthcare Corp(NHC)股票分析

$222.700

+0.445 (+0.20%)收盘时

Loading chart…
High
224.750
Open
224.450
VWAP
222.91
Vol
147.49K
Mkt Cap
1.66B
Low
221.278
Amount
32.88M
EV/EBITDA, TTM
0.00

National HealthCare Corporation is a senior healthcare company. The Company's principal business is the operation of skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, home health care services, hospice services, and behavioral health services. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. The Company operates or manages approximately 80 skilled nursing facilities with 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies.

nhccare.com

AI analysis of National Healthcare Corp (NHC)

buy

National Healthcare Corp is a good buy right now due to its strong earnings growth, with Q2 earnings reported at $40.32 million, a significant increase from $23.72 million last year, and a current price of $222.70, which is well below its Fibonacci resistance level of $229.58. However, the RSI is at 38.36, indicating it is approaching oversold territory, which could present a buying opportunity.

估值指标

The current forward P/E ratio for National Healthcare Corp (NHC) is 9.89, compared to its 5-year average forward P/E of 1.41.

Forward P/E

Strongly Overvalued
5Y Average P/E
1.41
Current P/E
9.89
高估
5.05
低估
-2.23

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
高估
0.00
低估
0.00

Alphio AI Price Scenarios for NHC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%NHC

$104.57

情景价格

B

Base

Base · 50%NHC

$86.97

情景价格

B

Bear

Bear · 25%NHC

$67.53

情景价格

Whales holding NHC

W

Washington H. Soul Pattinson and Company Limited

+ HoldingNHCPEN

+21.59%

3M Return

事件时间线

2026-08-07 (ET)

07:30:00

Q2 Revenue Reaches $408M vs $375M Last Year

2026-05-08 (ET)

07:11:00

Q1 Revenue Reaches $381.8M

2026-05-07 (ET)

16:50:00

National HealthCare Corporation Increases Quarterly Dividend to $0.67

2026-04-21 (ET)

16:50:00

National HealthCare to Acquire 32 Nursing Facilities for $560M

2025-05-08 (ET)

16:45:53

National Healthcare announces 4.9% increase in quarterly common dividend to 64c

资讯

NHC FAQ — answered by Alphio AI

National HealthCare Corporation is a senior healthcare company. The Company's principal business is the operation of skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, home health care services, hospice services, and behavioral health services. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. The Company operates or manages approximately 80 skilled nursing facilities with 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. It operates in the Healthcare sector (SERVICES-SKILLED NURSING CARE FACILITIES industry).

National Healthcare Corp is a good buy right now due to its strong earnings growth, with Q2 earnings reported at $40.32 million, a significant increase from $23.72 million last year, and a current price of $222.70, which is well below its Fibonacci resistance level of $229.58. However, the RSI is at 38.36, indicating it is approaching oversold territory, which could present a buying opportunity.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始